Identification of potential target genes of ROR-alpha in THP1 and HUVEC cell lines
Cagri Gulec1, Neslihan Coban1, Bilge Ozsait-Selcuk1
1Istanbul University, Institute for Experimental Medicine, Department of Genetics, Vakif Gureba C. Capa-Fatih, 34104 Istanbul, Turkey.
Abstract:
ROR-alpha is a nuclear receptor, activity of which can be modulated by natural or synthetic ligands. Due to its possible involvement in, and potential therapeutic target for atherosclerosis, we aimed to identify ROR-alpha target genes in monocytic and endothelial cell lines. We performed chromatin immunoprecipitation (ChIP) followed by tiling array (ChIP-on-chip) for ROR-alpha in monocytic cell line THP1 and endothelial cell line HUVEC. Following bioinformatic analysis of the array data, we tested four candidate genes in terms of dependence of their expression level on ligand-mediated ROR-alpha activity, and two of them in terms of promoter occupancy by ROR-alpha. Bioinformatic analyses of ChIP-on-chip data suggested that ROR-alpha binds to genomic regions near the transcription start site (TSS) of more than 3000 genes in THP1 and HUVEC. Potential ROR-alpha target genes in both cell types seem to be involved mainly in membrane receptor activity, signal transduction and ion transport. While SPP1 and IKBKA were shown to be direct target genes of ROR-alpha in THP1 monocytes, inflammation related gene HMOX1 and heat shock protein gene HSPA8 were shown to be potential target genes of ROR-alpha. Our results suggest that ROR-alpha may regulate signaling receptor activity, and transmembrane transport activity through its potential target genes. ROR-alpha seems also to play role in cellular sensitivity to environmental substances like arsenite and chloroprene. Although, the expression analyses have shown that synthetic ROR-alpha ligands can modulate some of potential ROR-alpha target genes, functional significance of ligand-dependent modulation of gene expression needs to be confirmed with further analyses.
Insights
This study identifies Retinoid-related Orphan Receptor alpha (ROR-alpha) target genes in monocytic and endothelial cells, revealing its role in regulating signaling and transport pathways, potentially impacting atherosclerosis treatment.
Area of Science:
- Molecular Biology
- Genomics
- Cardiovascular Research
Background:
- Retinoid-related Orphan Receptor alpha (ROR-alpha) is a nuclear receptor implicated in atherosclerosis.
- ROR-alpha activity can be modulated by various ligands, suggesting therapeutic potential.
Purpose of the Study:
- To identify ROR-alpha target genes in monocytic (THP1) and endothelial (HUVEC) cell lines.
- To investigate the role of ROR-alpha in cellular processes relevant to atherosclerosis.
Main Methods:
- Chromatin immunoprecipitation followed by tiling array (ChIP-on-chip) was performed for ROR-alpha.
- Bioinformatic analysis identified ROR-alpha binding sites.
- Gene expression analysis validated direct and potential target genes.
Main Results:
- ROR-alpha was found to bind near the transcription start site of over 3000 genes in both cell types.
- Potential target genes are involved in membrane receptor activity, signal transduction, and ion transport.
- SPP1 and IKBKA were identified as direct ROR-alpha targets in THP1 cells; HMOX1 and HSPA8 as potential targets.
Conclusions:
- ROR-alpha regulates signaling receptor activity and transmembrane transport.
- ROR-alpha influences cellular sensitivity to environmental substances.
- Ligand-dependent modulation of ROR-alpha target genes warrants further investigation for therapeutic applications in atherosclerosis.


